Contributed by Xiaoliang Sunney Xie; received November 7, 2023; accepted November 10, 2023; reviewed by Michel Nussenzweig and Fusheng Wang Considering the high risk of breakthrough infections in ...
Human immunoglobulin (Ig) began to be applied in the clinical practice with the treatment of primary immunodeficiencies. Quickly, applications of Ig increased, as its anti-inflammatory and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results